Clinical Trial Update: CMV Retinitis Retreatment Trial [Phase 2]

View source ↗

Summary

A Phase 2 retreatment trial investigating cytomegalovirus retinitis in HIV-infected individuals has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Retinitis
• HIV Infection

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Cytomegalovirus Retinitis, HIV Infections | Phase 2 | Status: COMPLETED